• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

PAX4 Polyklonaler Antikörper

PAX4 Polyklonal Antikörper für IF, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

IF, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 13018-2-AP

Synonyme

KPD, MODY9, paired box 4, Paired box protein Pax 4, PAX4

Filter:
  • Immunofluorescence (IF) / fluorescent staining of A549 cells using PAX4 Polyclonal antibody (13018-2-AP)

    IF Staining of A549 using 13018-2-AP

    Immunofluorescent analysis of A549 cells, using PAX4 antibody 13018-2-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).

Geprüfte Anwendungen

Produktinformation

13018-2-AP bindet in IF, ELISA PAX4 und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen PAX4 fusion protein Ag4111
Vollständiger Name paired box 4
Berechnetes Molekulargewicht 343 aa, 37 kDa
GenBank-ZugangsnummerBC074761
Gene symbol PAX4
Gene ID (NCBI) 5078
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

PAX4, a paired-box transcription factor, is a key regulator of pancreatic islet cell growth and differentiation. Differentiation of endoderm-derived endocrine pancreas is mediated through PAX4 and PAX6. PAX4 may act as a PAX6 repressor due to the competition for binding sites and lower transactivation potential of Pax-4. PAX4 has the potential to function as a tumor suppressor in human melanoma.